1 Min Read
May 2 (Reuters) - Mayne Pharma Group Ltd:
* NEW DRUG APPLICATION FOR SUBA-ITRACONAZOLE CAPSULES ACCEPTED FOR REVIEW BY U.S. FOOD AND DRUG ADMINISTRATION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.